Source: https://www.malignanttumors.org/jour/article/view/294
Timestamp: 2019-04-25 22:50:55+00:00

Document:
Статья посвящена эволюции хирургического, лучевого и лекарственного лечения рака тела матки на протяжении последних 20 лет. В ней обсуждаются результаты ключевых исследований по данной проблеме, изменившие подходы к лечению этой патологии.
1. Boronow, R. C. Endometrial cancer: not a benign disease / R. C. Boronow // Obstet. Gynecol.– 1976.– Vol. 47, N5.– P. 630–634.
2. Childers, J. M. Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer / J. M. Childers, E. A. Surwit // Gynecol. Oncol.– 1992.– Vol. 45, N1.– P. 46–51.
3. Cost and quality-of-life analyses of surgery for early endometrial cancer: laparotomy versus laparoscopy / N. M. Spirtos, J. B. Schlaerth, G. M. Gross et al. // Am. J. Obstet. Gynecol.– 1996.– Vol. 174, N6.– P. 1795–1799.
4. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study / J. M. Fowler, J. R. Carter, J. W. Carlson et al. // Gynecol. Oncol.– 1993.– Vol. 51, N2.–P. 187–192.
5. Phase III trial of laparoscopy versus laparotomy for surgical resection and comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group study / J. Walker, R. Mannel, M. Piedmonte et al. // Gynecol. Oncol.– 2006.– Vol. 101 (suppl. 1).– P. 11–12.
6. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study / J. Walker, M. Piedmonte, N. Spirtos et al. // J. Clin. Oncol.– 2012.– Vol. 30, N7.– P. 695–700.
7. Бохман, Я. В. Метастазы рака матки / Я. В. Бохман.– Л.: Медицина, 1976.– 159 с.
8. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study / W. T. Creasman, C. P. Morrow, B. N. Bundy et al. // Cancer.– 1987.– Vol. 60, N8 (suppl.).– P. 2035–2041.
9. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients / J. K. Chan, R. Urban, M. K. Cheung et al. // Cancer.– 2007.– Vol. 109, N12.– P. 2454–2460.
10. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study / ASTEC study group, Kitchener H., Swart A. M. et al. // Lancet.– 2009.– Vol. 373, N9658.– P. 125–136.
11. Creasman, W. T. The current status of lymphadenectomy in the management of endometrial cancer / W. T. Creasman // Womens Health (Lond. Engl).– 2011.– Vol. 7, N1.– P. 33–35.
12. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis // Y. Todo, H. Kato, M. Kaneuchi et al. // Lancet.– 2010.– Vol. 375, N9721.– P. 1165–1172.
13. Therapeutic impact of para-aortic lymphadenectomy in patients with high-risk, early stage and advanced stage endometrial carcinoma / Y. Suzuki, Y. Todo, K. Okamoto et al. // Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23–26 Oct 2010.– Abs. 1433.
14. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial / P. Benedetti Panici, S. Basile, F. Maneschi et al. // J. Natl. Cancer Inst.– 2008.– Vol. 100, N23.– P. 1707–1716.
15. The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer / J. P. Chino, E. Jones, A. Berchuk et al. // Int. J. Radiat. Oncol. Biol. Phys.– 2012.– Vol. 82, N5.– P. 1872–1879.
16. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up / N. Colombo, C. Creutzberg, F. Amant et al. // Radiother. Oncol.– 2015.– Vol. 117, N3.– P. 559–581.
17. Amant, F. Cancer of the corpus uteri / F. Amant, M. R. Mirza, C. L. Creutzberg // Int. J. Gynaecol. Obstet.– 2012.– Vol. 119, Suppl. 2.– P. S110—S117.
18. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer / L. J. Havrilesky, J. Cragun, B. Calingaert et al. // Gynecol. Oncol.– 2005.– Vol. 99, N3.– P. 689–695.
19. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer / J. M. Cragun, L. J. Havrilesky, B. Calingaert et al. // J. Clin. Oncol.– 2005.– Vol. 23, N16.– P. 3668–3675.
20. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer / F. Girardi, E. Petru, M. Heydarfadai et al. // Gynecol. Oncol.– 1993.– Vol. 49, N2.– P. 177–180.
21. Corpus: epithelial tumors / D. S. McMeekin, C. Yashar, S. Campos, R. J. Zaino // Principles and Practice of Gynecologic Oncology / R. R. Barakat, A. Berchuk, M. Markman, M. E. Randall (eds.).– 6th ed.– [S. l.]: Wolters Kluwer / Lippincott Williams & Wilkins, 2013.– P. 661–714.
22. Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. PostOperative Radiation Therapy in Endometrial Carcinoma / C. L. Creutzberg, W. L. van Putten, P. C. Koper et al. // Lancet.– 2000.– Vol. 355.– P. 1404–1411.
23. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study / H. M. Keys, J. A. Roberts, V. L. Brunetto et al. // Gynecol. Oncol.– 2004.– Vol. 92, N3.– P. 744–751.
24. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis / ASTEC/EN.5 Study Group, P. Blake, A. M. Swart et al. // Lancet.– 2009.– Vol. 373, N9658.– P. 137–146.
25. Johnson N., Cornes P. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis // BJOG.– 2007.– Vol. 114, N11.– P. 1313–1320.
26. Long-term outcomes after pelvic radiation for early-stage endometrial cancer / M. Onsrud, M. Cvancarova, T. P. Hellebust et al. // J. Clin. Oncol.– 2013.– Vol. 31, N31.– P. 3951–3956.
27. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients / J. Aalders, V. Abeler, P. Kolstad, M. Onsrud // Obstet. Gynecol.– 1980.– Vol. 56, N4.– P. 419–427.
28. Адъювантная дистанционная лучевая терапия при раке тела матки I – II стадий / В. М. Нечушкина, К. Ю. Морхов, В. В. Кузнецов, А. В. Егорова // Онкогинекология.– 2014.– № 4.– С. 37–44.
29. Нечушкина, В. М. Рак тела матки (факторы прогноза и тактика лечения): дис. … д-ра мед. наук: 14.01.12 / Нечушкина Валентина Михайловна.– М., 2013.– 445 с.
30. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis / A. Kong, N. Johnson, H. C. Kitchener, T. A. Lawrie // J. Natl. Cancer Inst.– 2012.– Vol. 104, N21.– P. 1625–1634.
31. Comparison of clinical and surgical staging in patients with endometrial carcinoma / T. A. Cowles, J. F. Magrina, B. J. Masterson, C. V. Capen // Obstet. Gynecol.– 1985.– Vol. 66, N3.– P. 413–416.
32. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study / R. C. Boronow, C. P. Morrow, W. T. Creasman et al. // Obstet. Gynecol.– 1984.– Vol. 63, N6.– P. 825–832.
33. Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis / J. C. Schink, J. R. Lurain, C. B. Wallemark, J. S. Chmiel // Obstet. Gynecol.– 1987.– Vol. 70, N2.– P. 216–219.
34. Conservative management of stage I endometrial carcinoma after surgical staging / J. M. Straughn, Jr., W. K. Huh, F. J. Kelly et al. // Gynecol. Oncol.– 2002.– Vol. 84, N2.– P. 194–200.
35. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy / J. M. Straughn, W. K. Huh, J. W. Orr, Jr. et al. // Gynecol. Oncol.– 2003.– Vol. 89, N2.– P. 295–300.
36. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial / R. A. Nout, V. T. H. B. M. Smit, H. Putter et al. // Lancet.– 2010.– Vol. 375, N9717.– P. 816–823.
37. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial / R. Maggi, A. Lissoni, F. Spina et al. // Br. J. Cancer.– 2006.– Vol. 95, N3.– P. 266–271.
38. Randomized phase III trial of pelvic radiotherapy versus cisplatin- based combined chemotherapy in patients with intermediate-and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study / N. Susumu, S. Sagae, Y. Udagawa et al. // Gynecol. Oncol.– 2008.– Vol. 108, N1.– P. 226–233.
39. Randomized phase III trial of WART versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a GOG study / M. Randall, V. Filiaci, H. Muss et al. // J. Clin. Oncol.– 2006.– Vol. 24, N1.– P. 36–44.
40. Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study / G. F. Fleming, V. L. Filiaci, R. C. Bentley et al. // Ann. Oncol.– 2004.– Vol. 15, N8.– P. 1173–1178.
41. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study / G. F. Fleming, V. L. Brunetto, D. Cella et al. // J. Clin. Oncol.– 2004.– Vol. 22, N11.– P. 2159–2166.
42. Randomized phase III noninferiority trial of first line chemotherapy for metastatic recurrent endometrial carcinoma: a Gynecologic Oncology Group study // D. Miller, V. Filiaci, G. Fleming et al. // Gynecol. Oncol.– 2012.– Vol. 125, N3.– P. 771.
Нечушкина В.М., Морхов К.Ю., Кузнецов В.В. ЭВОЛЮЦИЯ ЛЕЧЕНИЯ РАКА ТЕЛА МАТКИ. Злокачественные опухоли. 2016;(4s1):92-98.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.